Gene expression profiling of the synergy of 5-aza-2<sup>′</sup>-deoxycytidine and paclitaxel against renal cell carcinoma
<p>Abstract</p> <p>Background</p> <p>Renal cell carcinoma (RCC) is one of the most common kidney cancers and is highly resistant to chemotherapy. We previously demonstrated that 5-aza-2<sup>′</sup>-deoxycytidine (DAC) could significantly increase the suscept...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://www.wjso.com/content/10/1/183 |